HYPR HYPERFINE INC

Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022

Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022

GUILFORD, Conn., Oct. 27, 2022 (GLOBE NEWSWIRE) -- (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the third quarter 2022 on Thursday, November 10, 2022. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minutes before the start of the call. A live audio webcast and an archive of the presentation will be available through the Investors page of Hyperfine’s corporate website at .

About Hyperfine

Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.

Investor Contact

Marissa Bych

Gilmartin Group LLC



EN
27/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HYPERFINE INC

 PRESS RELEASE

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Hyperfine, Inc. Reports First Quarter 2025 Financial Results GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2025 financial results and provided a business update. “Our commercial efforts have primarily focused on the hospital business, where we’ve continued to experience longer and more variable sales cycles in the first quarter. During th...

 PRESS RELEASE

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Re...

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and provided a business update. “I am pleased with the many milestones we achieved in the fourth quarter of 2024. These set the stage well for us to execute on our expansion plan...

 PRESS RELEASE

Hyperfine, Inc. Reports Third Quarter 2024 Financial Results

Hyperfine, Inc. Reports Third Quarter 2024 Financial Results GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update. “The Hyperfine team delivered yet another strong quarter of financial performance across revenue growth, gross margin expansion, and disciplined cash management while executing a...

 PRESS RELEASE

Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Re...

Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance ─ Reports $3.6M in Q2 2024 Revenue; 50% Gross Margin─ Raises FY 2024 Revenue Guidance to $13-16M GUILFORD, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced second quarter 2024 financial results and provided a business update. “I am proud of the Hyperfine team, achieving record revenue and d...

 PRESS RELEASE

Hyperfine, Inc. Reports First Quarter 2024 Financial Results

Hyperfine, Inc. Reports First Quarter 2024 Financial Results GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update. “We have kicked off 2024 strong. I am pleased with our commercial progress shown by sales across US and international accounts, as well as the important milestones we hit in Q1 by commencin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch